Skip to main content

Table 1 The major human NAT2 alleles and their associated phenotypea.

From: Inferring haplotypes at the NAT2 locus: the computational approach

Allele

Nucleotide change b

Phenotype

 

G191A

C282T

T341C

C481T

G590A

A803G

G857A

 

NAT2*4

       

rapid

NAT2*5A

  

x

x

   

slow

NAT2*5B

  

x

x

 

x

 

slow

NAT2*5C

  

x

  

x

 

slow

NAT2*6A

 

x

  

x

  

slow

NAT2*6B

    

x

  

slow

NAT2*7A

      

x

slow

NAT2*7B

 

x

    

x

slow

NAT2*12A

     

x

 

rapid

NAT2*12B

 

x

   

x

 

rapid

NAT2*13

 

x

     

rapid

NAT2*14A

x

      

slow

NAT2*14B

x

x

     

slow

  1. Nucleotide substitutions shown in bold have a functional consequence on enzyme activity. Bold-faced alleles contain functional polymorphisms and are hence associated with the slow acetylator phenotype. Classification of NAT2 alleles into different clusters is based on the most functionally significant nucleotide substitution present: the NAT2*5, NAT2*6, NAT2*7 and NAT2*14 clusters possess signature nucleotide substitutions at positions 341, 590, 857 and 191, respectively and are hence all decreased function alleles ('slow alleles'). The others display enzymatic activity comparable to the rapid acetylator allele NAT2*4. There are significant interethnic differences in NAT2 allele distribution and frequency [14, 15].
  2. a Adapted from Hein et al. [3]. NAT2 nomenclature is accessible on the internet at website http://www.louisville.edu/medschool/pharmacology/NAT.html
  3. b Only changes from the reference sequence (NAT2*4) are indicated.